AIM: Japanese firm's AI algorithm for gastric cancer gets FDA's Breakthrough Device Deisgnation

The Food and Drug Administration has provided a Breakthrough Device Designation for its machine learning algorithm that has the ability to analyze endoscopy images for potential diagnosis of gastric cancer.